Michael J. Durkin

2.5k total citations
89 papers, 1.6k citations indexed

About

Michael J. Durkin is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Michael J. Durkin has authored 89 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 26 papers in Applied Microbiology and Biotechnology and 24 papers in Infectious Diseases. Recurrent topics in Michael J. Durkin's work include Antibiotic Use and Resistance (26 papers), Urinary Tract Infections Management (19 papers) and Patient Satisfaction in Healthcare (14 papers). Michael J. Durkin is often cited by papers focused on Antibiotic Use and Resistance (26 papers), Urinary Tract Infections Management (19 papers) and Patient Satisfaction in Healthcare (14 papers). Michael J. Durkin collaborates with scholars based in United States, United Kingdom and Switzerland. Michael J. Durkin's co-authors include Laura R. Marks, Stephen Y. Liang, Peter B. Lockhart, Martin H. Thornhill, Evan S. Schwarz, Kevin Hsueh, Nathanial S Nolan, David K. Warren, Rebekah W. Moehring and Deverick J. Anderson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michael J. Durkin

82 papers receiving 1.6k citations

Peers

Countries citing papers authored by Michael J. Durkin

Since Specialization

Citations

This map shows the geographic impact of Michael J. Durkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Durkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Durkin more than expected).

Fields of papers citing papers by Michael J. Durkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Durkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Durkin. The network helps show where Michael J. Durkin may publish in the future.

Co-authorship network of co-authors of Michael J. Durkin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Durkin. A scholar is included among the top collaborators of Michael J. Durkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Durkin. Michael J. Durkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of silencing automated penicillin cross-reactivity alerts on perioperative antibiotic prescribing and surgical site infection rates 2025 ·Infection Control and Hospital Epidemiology ·Michael J. Durkin, (unknown), (unknown), Andrew Atkinson, Jonas Marschall, (unknown), Kimberly G. Blumenthal	0
2	Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder 2025 ·Addiction ·Payel Roy, Ryan Colvin, Katelin B. Nickel, Rachael K. Ross, Michael J. Durkin, Katie J. Suda, Andrew Atkinson, Anne M. Butler	0
3	Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder 2024 ·Harm Reduction Journal ·Laura R. Marks, Michael J. Durkin, (unknown), Matthew S. Ellis	7
4	Comparative Safety of Different Antibiotic Regimens for the Treatment of Outpatient Community-Acquired Pneumonia Among Otherwise Healthy Adults 2024 ·Clinical Infectious Diseases ·Anne M. Butler, Katelin B. Nickel, Margaret A. Olsen, John M. Sahrmann, Ryan Colvin, Elizabeth Neuner, Caroline A. O’Neil, Victoria J. Fraser, Michael J. Durkin	2
5	Utilization of broad‐ versus narrow‐spectrum antibiotics for the treatment of outpatient community‐acquired pneumonia among adults in the United States 2024 ·Pharmacoepidemiology and Drug Safety ·Katelin B. Nickel, Michael J. Durkin, Margaret A. Olsen, John M. Sahrmann, Elizabeth Neuner, Caroline A. O’Neil, Anne M. Butler	1
6	1214. Short versus long antibiotic treatment duration for febrile urinary tract infection and acute pyelonephritis: A systematic review and meta-analysis 2023 ·Open Forum Infectious Diseases ·(unknown), (unknown), (unknown), Lauren Yaeger, Michael J. Durkin, Jonas Marschall	1
7	Personal protective equipment use among dental healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic and the impact of an educational video in clinical practice 2023 ·Infection Control and Hospital Epidemiology ·(unknown), Kimberly A. Reske, Daniel Park, (unknown), (unknown), Olivia G. Arter, (unknown), (unknown), Stephen Y. Liang, Michael J. Durkin, Jennie H. Kwon	3
8	How decisions are made: Antibiotic stewardship in dentistry 2023 ·Infection Control and Hospital Epidemiology ·(unknown), Katie J. Suda, Daphne Lew, Susan Rowan, (unknown), (unknown), Neel Shimpi, Randi E. Foraker, Michael J. Durkin	6
9	Salvage of Chronic Therapy‐Resistant Bilateral Charcot Foot Osteoarthropathy with Signs of Osteomyelitis 2022 ·Orthopaedic Surgery ·(unknown), (unknown), (unknown), Michael J. Durkin, (unknown), (unknown), (unknown), Larry Silver	1
10	Comparative Safety and Attributable Healthcare Expenditures Following Inappropriate Versus Appropriate Outpatient Antibiotic Prescriptions Among Adults With Upper Respiratory Infections 2022 ·Clinical Infectious Diseases ·Anne M. Butler, Derek S. Brown, Jason G. Newland, Katelin B. Nickel, John M. Sahrmann, Caroline A. O’Neil, Margaret A. Olsen, Rachel M Zetts, David Y. Hyun, Michael J. Durkin	9
11	Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs 2022 ·Clinical Infectious Diseases ·(unknown), Andrew Atkinson, (unknown), Sena Sayood, Nathanial S Nolan, (unknown), Jonas Marschall, Michael J. Durkin, Laura R. Marks	29
12	Patients With Serious Injection Drug Use–Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care 2022 ·Open Forum Infectious Diseases ·(unknown), Stephen Y. Liang, Evan S. Schwarz, David B. Liss, Rachel Winograd, Nathanial S Nolan, Michael J. Durkin, Laura R. Marks	29
13	Opportunities for penicillin allergy evaluation in dental clinics 2022 ·SHILAP Revista de lepidopterología ·(unknown), Michael J. Durkin, (unknown), (unknown), Margaret A. Fitzpatrick, Charlesnika T. Evans, M. Marianne Jurasic, Gretchen Gibson, Katie J. Suda	4
14	Low Knowledge of HIV PrEP Within a Midwestern US Cohort of Persons who Inject Drugs 2021 ·Open Forum Infectious Diseases ·Sena Sayood, Laura R. Marks, Rupa Patel, Nathanial S Nolan, Stephen Y. Liang, Michael J. Durkin	6
15	Staphylococcus aureus injection drug use-associated bloodstream infections are propagated by community outbreaks of diverse lineages 2021 ·SHILAP Revista de lepidopterología ·Laura R. Marks, Juan J. Calix, (unknown), Meghan A. Wallace, (unknown), Eric M. Ransom, Michael J. Durkin, Jeffrey P. Henderson, Carey‐Ann D. Burnham, Gautam Dantas	7
16	Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections 2021 ·Open Forum Infectious Diseases ·Laura R. Marks, Hilary Reno, Stephen Y. Liang, Evan S. Schwarz, David B. Liss, (unknown), Nathanial S Nolan, Michael J. Durkin	11
17	How to improve patient safety in fragile, conflict-affected and vulnerable settings: a Delphi study protocol 2021 ·BMJ Open ·Alexandra Shaw, (unknown), Kelsey Flott, Sheila Leatherman, Michael J. Durkin, Ara Darzi, Ana Luísa Neves	1
18	Concordance of antibiotic prescribing with the American Dental Association acute oral infection guidelines within Veterans’ Affairs (VA) dentistry 2021 ·Infection Control and Hospital Epidemiology ·(unknown), Michael J. Durkin, Gretchen Gibson, M. Marianne Jurasic, Ursula Patel, Linda Poggensee, Margaret A. Fitzpatrick, Kelly Echevarria, Jessina C. McGregor, Charlesnika T. Evans, Katie J. Suda	13
19	Use of ICD-10 Codes for Identification of Injection Drug Use–Associated Infective Endocarditis Is Nonspecific and Obscures Critical Findings on Impact of Medications for Opioid Use Disorder 2020 ·Open Forum Infectious Diseases ·Laura R. Marks, Nathanial S Nolan, (unknown), (unknown), Stephen Y. Liang, Michael J. Durkin	24
20	A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections 2019 ·The Journal of Infectious Diseases ·Laura R. Marks, (unknown), David K. Warren, David B. Liss, Stephen Y. Liang, Evan S. Schwarz, Michael J. Durkin	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact